Green Thumb Industries (GTBIF) and Glass House Brands (GLASF) topped Q3 2024 cannabis financial performance charts, showcasing exceptional adjusted EBITDA, operating cash flow, and free cash flow. This report analyzes their success, other strong performers like Grown Rogue and Vext Science, and the impact of tax strategies on industry cash flow.
Results for: Cannabis industry
California cannabis operator Gold Flora Corp. (GRAM) is teetering on the brink of receivership due to significant financial challenges, including over $236,000 in unpaid invoices. The company is implementing cost-cutting measures while simultaneously announcing expansion plans, highlighting the precarious position of many cannabis operators in a competitive market.
BLAZE Solutions announces enhanced integration with Metrc, revolutionizing cannabis dispensary inventory management. This partnership leverages Metrc Retail ID’s QR code system for efficient intake, eliminating re-labeling and saving significant time and money for dispensaries.
Decibel Cannabis Company Inc. (DB, DBCCF) announced the final closing of its private placement, raising $1.17 million to further integrate its recently acquired AgMedica BioScience. This follows a previous $2 million raise and positions Decibel for significant revenue growth in 2025.
Cronos Group Inc. (CRON) announced strong third-quarter 2024 results, driven by robust cannabis flower and extract sales in Canada, Israel, and international markets. The company also highlighted its strategic expansion of Cronos GrowCo, its 50%-owned cannabis cultivation subsidiary, and its commitment to cost savings and profitable growth.
Unity Rd., the first medical marijuana dispensary in South Dakota, is shutting its doors after facing numerous obstacles and a challenging legal environment. The closure comes on the heels of the state’s rejection of recreational cannabis legalization and highlights the ongoing struggles of the cannabis industry in the state.
Michigan’s booming cannabis market is overflowing with options, leaving consumers wondering what’s truly worth their money. A new weekly column by Metro Times aims to provide expert product reviews, focusing on factors beyond THC, like terpenes and cannabinoids, to help users find the best fit for their needs.
Auxly Cannabis Group Inc. (XLY, CBWTF) announced strong Q3 2024 financial results, driven by an 18% year-over-year increase in net revenue, reaching CA$33.3 million. The company also achieved a record adjusted EBITDA of CA$8.3 million, demonstrating its commitment to efficient growth and enhanced profitability.
Verano Holdings Corp. (VRNOF) saw its revenue dip in the third quarter of 2024, with challenges in Florida and Illinois markets contributing to the decline. Despite this, the company remains optimistic about its growth prospects in the state and is looking to capitalize on potential federal cannabis reform.
Canadian medical marijuana giant Aurora Cannabis Inc. reported strong second-quarter financial results, with revenue reaching CA$81.1 million, driven by robust growth in its global medical cannabis business. The company’s international revenue surged 93%, exceeding Canadian medical revenue for the first time, highlighting its strategic focus on expanding into lucrative international markets. Aurora’s Q2 2025 performance also saw a significant increase in adjusted EBITDA and a positive outlook for the coming quarters.